187 related articles for article (PubMed ID: 12889666)
1. Lipoprotein disorders and cardiovascular risk.
Genest J
J Inherit Metab Dis; 2003; 26(2-3):267-87. PubMed ID: 12889666
[TBL] [Abstract][Full Text] [Related]
2. Genetic hyperlipidemia and atherosclerosis.
Stone NJ
Artery; 1979 May; 5(5):377-97. PubMed ID: 262162
[No Abstract] [Full Text] [Related]
3. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of hyperlipoproteinaemia.
Shepherd J; Packard CJ
Scott Med J; 1986 Jul; 31(3):154-61. PubMed ID: 3798078
[TBL] [Abstract][Full Text] [Related]
5. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
[TBL] [Abstract][Full Text] [Related]
6. Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
Brunzell JD; Chait A; Albers JJ; Foster DM; Failor RA; Bierman EL
Am Heart J; 1987 Feb; 113(2 Pt 2):583-8. PubMed ID: 3812212
[TBL] [Abstract][Full Text] [Related]
7. Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology.
Mahley RW
Circulation; 1985 Nov; 72(5):943-8. PubMed ID: 4042302
[No Abstract] [Full Text] [Related]
8. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
Tani S; Matsumoto M; Nagao K; Hirayama A
J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
[TBL] [Abstract][Full Text] [Related]
9. Functional activities of hepatic lipoprotein receptors.
Havel RJ
Annu Rev Physiol; 1986; 48():119-34. PubMed ID: 3010812
[No Abstract] [Full Text] [Related]
10. Differential distribution of sphingomyelins among plasma lipoprotein classes.
Myher JJ; Kuksis A; Breckenridge WC; Little JA
Can J Biochem; 1981 Aug; 59(8):626-36. PubMed ID: 7296345
[TBL] [Abstract][Full Text] [Related]
11. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.
Guérin M; Bruckert E; Dolphin PJ; Chapman MJ
Eur J Clin Invest; 1996 Jun; 26(6):485-94. PubMed ID: 8817163
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)].
Loeper J; Goy-Loeper J; Rouffy J
Clin Chim Acta; 1979 Oct; 98(1-2):19-26. PubMed ID: 227624
[TBL] [Abstract][Full Text] [Related]
13. Metabolic heterogeneity in very low-density lipoproteins.
Shepherd J; Packard CJ
Am Heart J; 1987 Feb; 113(2 Pt 2):503-8. PubMed ID: 3812208
[No Abstract] [Full Text] [Related]
14. [Disorders of lipoprotein and cholesterol metabolism in familial hypercholesterolemia].
Wehr H
Pol Arch Med Wewn; 1982; 67(1-2):47-52. PubMed ID: 7050936
[No Abstract] [Full Text] [Related]
15. Differentiating hyperlipidaemia associated with antiretroviral therapy.
Mauss S; Stechel J; Willers R; Schmutz G; Berger F; Richter WO
AIDS; 2003 Jan; 17(2):189-94. PubMed ID: 12545078
[TBL] [Abstract][Full Text] [Related]
16. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
Kushwaha RS; Chait A; Hazzard WR
J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
[TBL] [Abstract][Full Text] [Related]
17. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
[TBL] [Abstract][Full Text] [Related]
18. Atherogenic lipoproteins resulting from genetic defects of apolipoproteins B and E.
Weisgraber KH; Innerarity TL; Rall SC; Mahley RW
Ann N Y Acad Sci; 1990; 598():37-48. PubMed ID: 2248450
[TBL] [Abstract][Full Text] [Related]
19. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
Hutt V; Klör HU; Wechsler JG; Ditschuneit H
J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
Quaschning T; Krane V; Metzger T; Wanner C
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
